Received: from PA4PR09MB5746.eurprd09.prod.outlook.com (2603:10a6:102:260::19) by AM8PR09MB5290.eurprd09.prod.outlook.com with HTTPS; Mon, 29 Apr 2024 12:25:21 +0000 Received: from AM8PR09MB5290.eurprd09.prod.outlook.com (2603:10a6:20b:36d::20) by PA4PR09MB5746.eurprd09.prod.outlook.com (2603:10a6:102:260::19) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.7519.35; Mon, 29 Apr 2024 12:25:18 +0000 Received: from AM8PR09MB5290.eurprd09.prod.outlook.com ([fe80::2393:681:aa94:1637]) by AM8PR09MB5290.eurprd09.prod.outlook.com ([fe80::2393:681:aa94:1637%6]) with mapi id 15.20.7519.031; Mon, 29 Apr 2024 12:25:18 +0000 From: "Olga Loos" To: "TA tpd" Cc: "EER Ingredientreporting" References: In-Reply-To: Subject: RE: Request for Assistance with Inactive Products in EU-CEG System Date: Mon, 29 Apr 2024 15:25:18 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_005F_01DA9CAD.86712C10" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQHakMO5qAR3pd5n70CwiXfcPtZHsrF/PTlw X-MS-Has-Attach: X-MS-TNEF-Correlator: X-MS-Exchange-Organization-AuthSource: AM8PR09MB5290.eurprd09.prod.outlook.com X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-Organization-Network-Message-Id: 74b7f1c7-4cc5-4d58-7602-08dc68476e7a X-MS-Exchange-Transport-EndToEndLatency: 00:00:03.1204810 X-MS-Exchange-Processed-By-BccFoldering: 15.20.7519.031 Content-Language: nl x-ms-exchange-organization-originalclientipaddress: 213.34.136.250 x-ms-exchange-organization-originalserveripaddress: 2603:10a6:20b:36d::20 acceptlanguage: nl-NL, en-US Authentication-Results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=st-group.com; x-ms-publictraffictype: Email x-ms-traffictypediagnostic: AM8PR09MB5290:EE_|PA4PR09MB5746:EE_|AM8PR09MB5290:EE_ x-ms-office365-filtering-correlation-id: 74b7f1c7-4cc5-4d58-7602-08dc68476e7a x-microsoft-antispam: BCL:0;ARA:13230031|376005|366007|41050700001; x-microsoft-antispam-message-info: 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 X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: AM8PR09MB5290.eurprd09.prod.outlook.com X-MS-Exchange-CrossTenant-Network-Message-Id: 74b7f1c7-4cc5-4d58-7602-08dc68476e7a X-MS-Exchange-CrossTenant-originalarrivaltime: 29 Apr 2024 12:25:18.4922 (UTC) X-MS-Exchange-CrossTenant-fromentityheader: Hosted X-MS-Exchange-CrossTenant-id: 49d0d517-409a-4335-ae82-c45e8c80bd45 X-MS-Exchange-Transport-CrossTenantHeadersStamped: PA4PR09MB5746 x-forefront-antispam-report: CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:AM8PR09MB5290.eurprd09.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230031)(376005)(366007)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-mailboxtype: HOSTED X-MS-Exchange-CrossTenant-userprincipalname: n041lqh83AIGtW+V3XrWFDCJXjCxsIu7DWVASqjEW/2tzJuY+GOas9gp3hbZsNxoBKwYlO5oMg92bKpwwASoGQ== msip_labels: MSIP_Label_1e776b66-80ea-4b8b-872b-6142b0ecbd13_ActionId=90dfc2dc-2230-4ef6-be0c-83c128a529a5;MSIP_Label_1e776b66-80ea-4b8b-872b-6142b0ecbd13_ContentBits=0;MSIP_Label_1e776b66-80ea-4b8b-872b-6142b0ecbd13_Enabled=true;MSIP_Label_1e776b66-80ea-4b8b-872b-6142b0ecbd13_Method=Standard;MSIP_Label_1e776b66-80ea-4b8b-872b-6142b0ecbd13_Name=defa4170-0d19-0005-0004-bc88714345d2;MSIP_Label_1e776b66-80ea-4b8b-872b-6142b0ecbd13_SetDate=2024-04-17T12:25:03Z;MSIP_Label_1e776b66-80ea-4b8b-872b-6142b0ecbd13_SiteId=49d0d517-409a-4335-ae82-c45e8c80bd45; x-ms-exchange-atpmessageproperties: SA|SL X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910001)(944506478)(944626604)(920097)(425001)(930097)(140003); x-ms-exchange-organization-recordreviewcfmtype: 0 This is a multipart message in MIME format. ------=_NextPart_000_005F_01DA9CAD.86712C10 Content-Type: text/plain; charset="Windows-1252" Content-Transfer-Encoding: 8bit Dear Sir/ Madam, I hope you are doing fine. Could you please provide me with a list of ingredients that are not permitted for use in our products? I need to ensure compliance with regulations and make any necessary adjustments to our formulations. Your assistance with this matter would be greatly appreciated. Thanks, in advance. Kind Regards Olga Loos Ingredient Specialist Europe Mobile +31 (0) 615 078 064 Van: Olga Loos <Olga.Loos@st-group.com> Verzonden: woensdag 17 april 2024 14:35 Aan: tpd@terviseamet.ee CC: EER Ingredientreporting <Ingredientreporting@st-group.com> Onderwerp: Request for Assistance with Inactive Products in EU-CEG System Dear Sir/ Madam, I hope you are doing fine. I’m still looking for the two products they are market Inactive in the EU-CEG system. The products contain a substance that are prohibited in accordance with § 8(4) of The Tobacco Act . To ensure compliance and avoid future complaints, we are seeking clarification on the exact nature of this issue. Understanding the specific reasons for the prohibition of these substances will enable us to update our system regulations accordingly for Estonia. Your prompt assistance in providing details on the prohibited substances and any relevant regulatory information would be greatly appreciated. Thank you for your attention to this matter. Kind Regards Olga Loos Ingredient Specialist Europe Mobile +31 (0) 615 078 064 Van: EER Ingredientreporting <Ingredientreporting@st-group.com> Verzonden: dinsdag 26 maart 2024 15:38 Aan: Olga Loos <Olga.Loos@st-group.com> Onderwerp: FW: EU-CEG submissions for Estonian market ________________________________ From: TA tpd <tpd@terviseamet.ee> Sent: Tuesday, March 26, 2024 3:38:08 PM (UTC+01:00) Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna To: EER Ingredientreporting <Ingredientreporting@st-group.com> Subject: EU-CEG submissions for Estonian market [EXTERNAL MAIL] - Be careful. Dear Sir/ Madam, This is to inform you that the submissions number 00053-20-11797 and 00053-20-11786 have been marked inactive in the EU-CEG system. The products contain substances that are prohibited in accordance with § 8(4) of The Tobacco Act. (https://www.riigiteataja.ee/en/eli/503052023002/consolide) Best regards Chemical Safety Department Republic of Estonia Health Board +372 794 3500 info@terviseamet.ee www.terviseamet.ee Paldiski mnt 81, 10614 Tallinn ------=_NextPart_000_005F_01DA9CAD.86712C10 Content-Type: text/html; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable

Dear Sir/ Madam,

=A0

I hope you are doing = fine.

=A0

Could you please provide me with a = list of ingredients that are not permitted for use in our products? I = need to ensure compliance with regulations and make any necessary = adjustments to our formulations.

Your assistance with this matter = would be greatly appreciated.

=A0

=A0

Thanks, in = advance.

=A0

=A0

Kind = Regards

=A0

Olga = Loos

Ingredient = Specialist Europe

=A0

Mobile +31 = (0) 615 078 064

=A0

Van: Olga Loos = <Olga.Loos@st-group.com>
Verzonden: woensdag 17 april 2024 14:35
Aan: tpd@terviseamet.ee
CC: EER Ingredientreporting = <Ingredientreporting@st-group.com>
Onderwerp: Request for Assistance with Inactive Products in = EU-CEG System

=A0

Dear Sir/ Madam, =

=A0

I hope = you are doing fine.

=A0

I=92m still looking = for the two products they are market Inactive in the EU-CEG = system.

=A0

The products contain a substance that are prohibited in accordance = with =A7 8(4) of The Tobacco Act .

=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0= =A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0= =A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0= =A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0= =A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0= =A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0= =A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0= =A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0= =A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0= =A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0=A0 =

To ensure compliance and avoid = future complaints, we are seeking clarification on the exact nature of = this issue. Understanding the specific reasons for the prohibition of = these substances will enable us to update our system regulations = accordingly for Estonia.

=A0

Your prompt assistance in providing = details on the prohibited substances and any relevant regulatory = information would be greatly appreciated.

=A0

Thank you for your attention to = this matter.

=A0

=A0

=A0

=A0

Kind = Regards

=A0

Olga = Loos

Ingredient = Specialist Europe

=A0

Mobile +31 = (0) 615 078 064

=A0

Van: EER Ingredientreporting = <Ingredientreporting@st-g= roup.com>
Verzonden: dinsdag 26 maart 2024 15:38
Aan: Olga Loos <Olga.Loos@st-group.com>
= Onderwerp: FW: EU-CEG submissions for Estonian = market

=A0

=A0=

From: TA tpd = <tpd@terviseamet.ee>
Sent: Tuesday, March 26, 2024 3:38:08 PM (UTC+01:00) = Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna
To: EER Ingredientreporting <Ingredientreporting@st-g= roup.com>
Subject: EU-CEG submissions for Estonian market

=A0

[EXTERNAL MAIL] - = Be = careful.=A0

=A0<= /Span>

=A0

Dear Sir/ Madam,

=A0

This is to inform you that the = submissions number 00053-20-11797 and 00053-20-11786 have been marked = inactive in the EU-CEG system.

The = products contain substances that are prohibited in accordance with =A7 = 8(4) of The Tobacco Act. (https:= //www.riigiteataja.ee/en/eli/503052023002/consolide)

=A0

Best regards

=A0

Chemical Safety = Department

Republic of Estonia Health Board

+372=A0794 3500

info@terviseamet.ee
www.terviseamet.ee

Paldiski mnt 81, 10614 = Tallinn

=A0

=A0

=A0

------=_NextPart_000_005F_01DA9CAD.86712C10--